NCT01378208

Brief Summary

The Danish Food Administration recommends eating three main meals and three small meals a day in order to maintain a healthy lifestyle. However, there is little research to support this concept- moreover, many studies shows that fasting can have a positive impact on our health. HYPOTHESIS AND PURPOSE The investigators hypothesize, that the number of meals per day in order to maintain a healthy lifestyle will not differ in normal weight subjects. The investigators will include 1) healthy, normal weight subjects. The investigators will study the effects of two daily meals. More specifically, the investigators want to better understand how the body reacts to long-term, intermittent fasting (14 h /day for 4 weeks). The investigators will assess cognitive function, dietary intake, appetite regulation, fitness, glucose and insulin responses, as well as fat and muscle composition of the body before, during, and after the study. Our long-term goals are to compare the effects of intermittent fasting with acute fasting. All of this is in an effort to establish how our eating habits ultimately affect our health and to, perhaps, contribute to new recommendations for healthy eating in normal weight population. BACKGROUND Obesity and diabetes are increasing health threats facing the Western world today, despite abundant research efforts and campaigns to prevent such outcomes. Throughout the years, as the incidence of both obesity and diabetes in the general population has increased, so too has the typical number of daily meals. A once common three meals per day has now increased to six meals per day, in many instances. Recent animal research has shown that intermittent fasting (one or two meals per day) over a long period of time can improve cardiovascular health and prevent chronic diseases. Biochemically, fasting leads to an activation of metabolic mechanisms designed to preserve carbohydrates and increase the dependence on energy produced by the metabolism of fat. There is little scientific evidence regarding the number of meals per day that proves to be the healthiest, and those studies that do exist have opposing conclusions. Several theories do exist regarding the number of meals per day that affect us in the most favorable way, but these are just theories. Our study is the first to assess, in both a systematic and controlled setting, how long-term, intermittent fasting affects the human body.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

June 15, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 22, 2011

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
Last Updated

November 20, 2013

Status Verified

November 1, 2013

Enrollment Period

2 years

First QC Date

June 15, 2011

Last Update Submit

November 19, 2013

Conditions

Keywords

Intermittent fastingMeal frequencybody compositioncognitive functionglucose metabolism

Outcome Measures

Primary Outcomes (1)

  • oral glucose tolerance test and cognitive function

    OGTT with stable isotopes. To see the effect of plasma glucose mmol/L and plasma insulin pmol/L 1 month after intervention (2 months from beginning of the study). Before, during, and after the intervention the subjects will complete cognitive tests for e.g. concentration, mood and appetite.

    2 months

Secondary Outcomes (1)

  • Continuous glucose monitoring (CGM), body composition, and physical activity.

    2 months

Study Arms (1)

Normal weight

EXPERIMENTAL

Body Mass Index between 18-25 kg/m2 Age between 18-35 years male

Behavioral: Intermittent fasting - the effect on glucose metabolism, body composition and cognitive function

Interventions

Each of the 10 subjects must through a period of monitoring (four weeks) before the study period (four weeks). Before, during, and after both the monitoring period and the study period, the subjects will undergo tests at Rigshospitalet. DAY 1: Inclusion and exclusion of subjects DAY 1 to DAY 28: Monitoring period (usual lifestyle) * 28 days of dietary monitoring * 28 days measurement by pedometer DAY 1, DAY 28 \& DAY 56: Test 1 * Oral glucose tolerance test with stable isotopes * Fat and muscle biopsies DAY 2, DAY 29 \& DAY 57: Test 2 * DXA scanning * Resting Metabolic Rate Measurement * VO2max test on bicycle * Cognitive testing * MRI of the brain and abdomen DAY 9, DAY 19, DAY 38 \& DAY 48: Test 3 * Actiheart for 3 days * 72-hour blood glucose monitoring with CGMS System DAY 29 to DAY 57: INTERVENTION * Fasting from 7am - 9pm * 28 days of dietary monitoring * 28 days measurement by pedometer

Normal weight

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Physically active, defined as at least 8,000 steps per day
  • Regular meal frequency, i.e. energy intake=energy utilized, and eating between 3-6 meals per day

You may not qualify if:

  • Daily medications
  • Acute illness within the past two weeks (infection, fever, or surgery)
  • Chronic disease, including cancer, heart, liver, kidney, and respiratory diseases, as well as metabolic diseases, such as diabetes
  • Alcohol abuse or more than 14/21 units (women/men) consumed per week
  • Smoking, including occasional smoking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre of Inflammation and Metabolism, Rigshospitalet

Copenhagen OE, Copenhagen, 2100, Denmark

Location

MeSH Terms

Conditions

Intermittent Fasting

Interventions

Body Composition

Condition Hierarchy (Ancestors)

FastingFeeding BehaviorBehavior

Intervention Hierarchy (Ancestors)

Biochemical PhenomenaChemical PhenomenaMetabolismBody ConstitutionPhysiological Phenomena

Study Officials

  • Bente K Pedersen, Professor

    Rigshospitalet, Denmark

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
CIM Administrator

Study Record Dates

First Submitted

June 15, 2011

First Posted

June 22, 2011

Study Start

June 1, 2011

Primary Completion

June 1, 2013

Study Completion

June 1, 2013

Last Updated

November 20, 2013

Record last verified: 2013-11

Locations